Managers / Q4 2024 · view latest →
Cambridge Financial Group, Inc.
CIK 0001334199 · 4100 HORIZONS DRIVE, SUITE 101, COLUMBUS, OH, 43220 · 614-457-1530
Summary
Cambridge Financial Group, Inc. reported $242M in U.S.-listed holdings across 33 positions for Q4 2024.
Its largest position, AVGO, represents 5.5% of the portfolio.
Compared with Q2 2024, the fund opened 2 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 93.6% · $226M
- Other · 6.2% · $15M
- ETP · 0.2% · $532,066
Quarter-over-Quarter Changes full breakdown →
vs Q2 2024 (amended baseline) · note: prior filed quarter, not the immediately preceding one
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TRVCCitigroup | NEW | +99.8K | 99.8K | +$7M | $7M |
| BBYBest Buy Co. | NEW | +75.8K | 75.8K | +$7M | $7M |
| AVGOBroadcom Inc | ADDED | +51.1K | 57.9K | +$3M | $13M |
| MSCIMSCI | SOLD OUT | −12.9K | 0 | −$6M | $0 |
| WBAWALGREENS BOOTS ALLIANCE INC | SOLD OUT | −345.6K | 0 | −$4M | $0 |
| GEVGE VERNOVA INC | TRIMMED | −7.4K | 6.4K | −$268,838 | $2M |
| NVDANVIDIA CORP | TRIMMED | −21.7K | 62.4K | −$2M | $8M |
| MPCMarathon Petroleum | ADDED | +6.0K | 40.3K | −$326,489 | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $267M | 33 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $262M | 33 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $258M | 33 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $198M | 33 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $230M | 33 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $242M | 33 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $222M | 33 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $226M | 32 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $200M | 32 | Feb 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $184M | 32 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 32 | Feb 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $166.2B | 31 | Nov 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $223.0B | 32 | May 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $254.7B | 32 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $227.3B | 30 | Oct 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $233.9B | 32 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $226.5B | 32 | May 7, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $210.2B | 32 | Feb 1, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $190.4B | 32 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $177.3B | 32 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $148.2B | 32 | May 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $196.5B | 31 | Feb 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $183.8B | 31 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $187.9B | 31 | Jul 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $184.4B | 31 | May 3, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $156.5B | 31 | Feb 1, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.